zopolrestat has been researched along with Diabetes Mellitus, Type 1 in 5 studies
zopolrestat: structure given in first source
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hodgkinson, AD | 1 |
Bartlett, T | 1 |
Oates, PJ | 2 |
Millward, BA | 1 |
Demaine, AG | 1 |
Johnson, BF | 1 |
Nesto, RW | 1 |
Pfeifer, MA | 1 |
Slater, WR | 1 |
Vinik, AI | 1 |
Chyun, DA | 1 |
Law, G | 1 |
Wackers, FJ | 1 |
Young, LH | 1 |
Ramasamy, R | 3 |
Schaefer, S | 2 |
Trueblood, N | 2 |
1 trial available for zopolrestat and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration.
Topics: Aldehyde Reductase; Benzothiazoles; Cardiac Output; Diabetes Mellitus, Type 1; Diabetes Mellitus, Ty | 2004 |
4 other studies available for zopolrestat and Diabetes Mellitus, Type 1
Article | Year |
---|---|
The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy.
Topics: Adult; Aged; Aldehyde Reductase; Antioxidants; Benzothiazoles; Blood Glucose; Catalase; Cells, Cultu | 2003 |
Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
Topics: Adenosine Triphosphate; Aldehyde Reductase; Animals; Benzothiazoles; Blood Glucose; Diabetes Mellitu | 1997 |
Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts.
Topics: Aldehyde Reductase; Animals; Benzothiazoles; Blood Pressure; Citric Acid Cycle; Diabetes Mellitus, T | 1998 |
Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion.
Topics: Aldehyde Reductase; Animals; Benzothiazoles; Cytosol; Diabetes Mellitus, Type 1; Enzyme Inhibitors; | 1998 |